Oxidative stress and lowered total antioxidant status are associated with a history of suicide attempts

Journal of Affective Disorders

Volumn 150, Issue 3, 2013, Pages 923-930

  Vargas, Heber Odebrecht ^a,b   Nunes, Sandra Odebrecht Vargas ^a,b   De Castro, Marcia Pizzo ^b   Bortolasci, Chiara Cristina ^a   Barbosa, Décio Sabbatini ^a   Morimoto, Helena Kaminami ^a   Venugopal, Kamalesh ^d   Doddd, Seetal ^c,d,f   Maes, Michael ^d   Berk, Michael ^c,d,e,f,g  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b Center of Approach and Treatment for Smokers   (Brazil)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d DEAKIN UNIVERSITY   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f BARWON HEALTH   (Australia)

^g FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

Depressive disorders; Inflammation; Metabolism; Nicotine dependence; Oxidative stress; Suicide

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; ANTIOXIDANT; C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 6; LIPID HYDROPEROXIDE; MALONALDEHYDE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANXIETY; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR DISORDER; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; DISEASE MARKER; EDUCATIONAL STATUS; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MARRIAGE; METABOLIC DISORDER; METABOLIC SYNDROME X; NITROSATIVE STRESS; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT; TOTAL ANTIOXIDANT POTENTIAL;

DEPRESSIVE DISORDERS; INFLAMMATION; METABOLISM; NICOTINE DEPENDENCE; OXIDATIVE STRESS; SUICIDE;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BRAZIL; C-REACTIVE PROTEIN; DEPRESSION; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NITRIC ACID; OXIDATIVE STRESS; RISK FACTORS; SELF REPORT; SMOKING; SUICIDE, ATTEMPTED; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84888315939     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2013.05.016     Document Type: Article

References (57)

1. Alberti, K.G., Zimmet, P., Shaw, J., 2005. The metabolic syndrome-a new worldwide definition. Lancet 366 (9491), 1059-1062.
2. Alberti, K.G., Eckel, R.H., Grundy, S.M., Zimmet, P.Z., Cleeman, J.I., Donato, K.A., Fruchart, J.C., James, W.P., Loria, C.M., Smith Jr., S.C., 2009. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120 (16), 1640-1645.
3. Almeida, O.P., Norman, P., Hankey, G.J., Jamrozik, K., Flicker, L., 2007. The association between C-reactive protein concentration and depression in later life is due to poor physical health: results from the Health in Men Study (HIMS). Psychological Medicine 37, 1775-1786.
4. Bergquist, J., Träskman-Bendz, L., Lindström, M.B., Ekman, R., 2002. Suicide-attempters having immunoglobulin G with affinity for dopamine in cerebrospinal fluid. European Neuropsychopharmacology 12, 153-158.
5. Berk, M., Kapczinski, F., Andreazza, A.C., Dean, O.M., Giorlando, F., Maes, M., Yucel, M., Gama, C.S., Dodd, S., Dean, B., Magalhàes, P.V.S., Amminger, P., McGorry, P., Malhi, G.S., 2011. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neuroscience and Biobehavioral Reviews 35 (3), 804-817.
6. Breslau, N., Schultz, L.R., Johnson, E.O., Peterson, E.L., Davis, G.C., 2005. Smoking and the risk of suicidal behavior: a prospective study of a community sample. Archives of General Psychiatry 62 (3), 328-334.
7. Bronisch, T., Höfler, M., Lieb, R., 2008. Smoking predicts suicidality: findings from a prospective community study. Journal of Affective Disorders 108, 135-145.
8. Burke, A., Fitzgerald, G.A., 2003. Oxidative stress and smoking-induced vascular injury. Progress in Cardiovascular Diseases 46 (1), 79-90.
9. Capuron, L., Su, S., Miller, A.H., Bremner, J.D., Goldberg, J., Vogt, G.J., Maisano, C., Jones, L., Murrah, N.V., Vaccarino, V., 2008. Depressive symptoms and metabolic syndrome: is inflammation the underlying link? Biological Psychiatry 64 (10), 896-900.
10. Chen, C-C., Li, T.C., Chang, P-C., Liu, C.S., Lin, W-Y., Wu, M-T., Li, C-I., Lai, M-M., Lin, CC., 2008. Association among cigarette smoking, metabolic syndrome, and its individual components: the metabolic syndrome study in Taiwan. Metabolism 57, 544-548.
11. Danner, M., Kasl, S.V., Abramson, J.L., Vaccarino, V., 2003. Association between depression and elevated C-reactive protein. Psychosomatic Medicine 65, 347-356.
12. Del Ben, C.M., Vilela, J.A.A, Crippa, J.A.S., Hallak, J.E.C., Labate, C.M., Zuardi, A.W., 2001. Confiabilidade da "Entrevista Clínica Estruturada para o D.S.M.-IV"- versào clínica traduzida para o portugués. Revista Brasileira de Psiquiatria 23 (3), 156-159.
13. Elovainio, M., Aalto, A.M., Kivimäki, M., Pirkola, S., Sundvall, J., Lönnqvist, J., Reunanen, A., 2009. Depression and C-reactive protein: population-based Health 2000 study. Psychosomatic Medicine 71, 423-430.
14. Facchini, F.S., Hollenbeck, C.B., Jeppesen, J., Chen, Y.D., Reaven, G.M., 1992. Insulin resistance and cigarette smoking. Lancet 339 1128-30.
15. Fiedorowicz, J.G., Coryell, W.H., 2007. Cholesterol and suicide attempts: a prospective study of depressed inpatients. Psychiatric Research 152 (1), 11-20.
16. Foley, D.L., Morley, K.I., Madden, P.A., Heath, A.C., Whitfield, J.B., Martin, NG., 2010. Major depression and the metabolic syndrome. Twin Research and Human Genetics 13 (4) 347-58.
17. Ford, D.E., Erlinger, T.P., 2004. Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. Archives of Internal Medicine 164, 1010-1014.
18. Forlenza, M.J., Miller, G.E., 2006. Increased serum levels of 8-hydroxy-2'-deoxygua-nosine in clinical depression. Psychosomatic Medicine 68 (1), 1-7.
19. Goodwin, R.D, Prescott, M.R., Tamburrino, M., Calabrese, J.R., Liberzon, I., Galea, S., 2013. Cigarette smoking and subsequent risk of suicidal ideation among National Guard Soldiers. Journal of Affective Disorders 145, 111-114.
20. Hamer, M., Molloy, G.J., de Oliveira, Demakakos, P., 2009. Persistent depressive symptomatology and inflammation: to what extent do health behaviours and weight control mediate this relationship? Brain Behav. Immun. 23, 413-418.
21. Hughes, J.R., 2008. Smoking and suicide: a brief overview. Drug and Alcohol Dependence 98, 169-178.
22. Jentzch, A.M., Bachman, H., Fürst, P., Biesalski, H.K., 1996. Improved analysis of malondialdehyde in human body fluids. Free Radical Biology and Medicine 20, 251-256.
23. Jiang, Z., Woollard, A.C.S., Wolff, S.P., 1991. Lipid hydroperoxide measurement by oxidation of Fe2+ in the presence of xylenol orange. Comparison with the TBA assay and an iodometric method. Lipids 26 (10), 353-356.
24. Kim, Y.K., Myint, A.M., 2004. Clinical application of low serum cholesterol as an indicator for suicide risk in major depression. Journal of Affective Disorders 81, 161-166.
25. Kim, Y.K., Lee, S.W., Kim, S.H., Shim, S.H., Han, S.W., Choi, S.H., Li, B.H., 2007. Differences in cytokines between non-suicidal patients and suicidal patients in major depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 32, 356-361.
26. Kim Y.K., Lee S-W., Kim S-H., Shim S-H., Han S-W., Choi S-H., Lee B-H., 2008. Differences in cytokines between non-suicidal patients and suicidal patients in major depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry 32, 356-361.
27. Kozumplik, O., Uzun, S., 2011. Metabolic syndrome in patients with depressive disorder-features of comorbidity. Psychiatria Danubina 23 (1), 84-88.
28. Lasser, K., Boyd, J.W., Woolhandler, S., Himmelstein, D.U., McCormick, D., Bor, D.H., 2000. Smoking and mental illness: a population-based prevalence study. JAMA 284 (20), 2606-2610.
29. Lear, S.A., James, P.T., Ko, G.T., Kumanyik, S., 2010. Appropriateness of waist circumference and waist-to-hip ratio cutof fs for different ethnic groups. European Journal of Clinical Nutrition 64, 42-61.
30. Leonard, L., Maes, M., 2012. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophsyology of unipolar depression. Neuroscience and Biobehavioral Reviews 36 (12), 764-785.
31. Lester, D., 1993. Suicidal behavior in bipolar and bipolar affective disorders: a meta-analysis. Journal of Affective Disorders 27, 117-121.
32. Li, Y., Zhang, J., 2007. Serum concentrations of antioxidant vitamins and carotenoids are low in individuals with a history of attempted suicide. Nutritional Neuroscience 10 (1-2), 51-58.
33. Liukkonen, T., Silvennoinen-Kassinen, S., Jokelainen, J., Räsänen, P., Leinonen, M., Meyer-Rochow, V.B., Timonen, M., 2006. The association between C-reactive protein levels and depression: results from the northern Finland 1966 birth cohort study. Biological Psychiatry 60, 825-830.
34. Maes, M., Bosmans, E., Ranjan, R., Vandoolaeghe, E., Meltzer, H.Y., De Ley, M., Berghmans, R., Stans, G., Desnyder, R., 1996. Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: effects of antipsychotic drugs. Schizophrenia Research 21 (1), 39-50.
35. Maes, M., Smith, R., Christophe, A., Vandoolaeghe, E., Van Gastel, A., Neels, H., Demedts, P., Wauters, A., Meltzer, H.Y., 1997. Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: relationship with immune-inflammatory markers. Acta Psychiatrica Scandinavica 95 (3), 212-221.
36. Maes, M., Chang, Y.S., Galecki, P., Berk, M., 2011. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Progress in Neuro-Psychopharmacology and Biological Psychiatry 35, 676-692.
37. Malone, K.M., Waternaux, C., Haas, G.L., Cooper, T.B., Li, S., Mann, J.J., 2003. Cigarette smoking, suicidal behavior, and serotonin function in major psychiatric disorders. American Journal of Psychiatry 160, 773-779.
38. McGee, R., Williams, S., Nada-Raja, S., 2005. Is cigarette smoking associated with suicidal ideation among young people? American Journal of Psychiatry 162 (3) 619-20.
39. Mendlovic, S., Mozes, E., Eilat, E., Doron, A., Lereya, J., Zakuth, V., Spirer, Z., 1999. Immune activation in non-treated suicidal major depression. Immunology Letters 67 (2), 105-108.
40. Miller, A.H., Maletic, V., Raison, C.L., 2009. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biological Psychiatry 65, 732-741.
41. Moylan, S., Maes, M., Wray, N.R., Berk, M., 2012. The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Molecular Psychiatry.
42. Nässberger, L., Träskman-Bendz, L., 1993. Increased soluble interleukin-2 receptor concentrations in suicide attempters. Acta Psychiatrica Scandinavica 88 (1), 48-52.
43. Navarro-Gonzálvez, J.A., García-Benayas, C., Arenas, J., 1998. Semiautomated measurement of nitrate in biological fluids. Clinical Chemistry 44, 679-681.
44. Nunes, S.O.V., Vargas, H.O., Brum, J., Prado, E., Vargas, M.M., de Castro, M.R.P., Dodd, S., Berk, M., 2012. A comparison of inflammatory markers in depressed and non-depressed smokers. Nicotine and Tobacco Research 14, 540-546.
45. Pasco, J.A., Williams, L.J., Jacka, F.N., Ng, F., Henry, M.J., Nicholson, G.C., Kotowicz, M. A., Berk, M., 2008. Tobacco smoking as a risk factor for major depressive disorder: population-based study. British Journal of Psychiatry 193, 322-326.
46. Rabe-Jablonska, J., Poprawska, I., 2000. Levels of serum total cholesterol and LDL-cholesterol in patients with major depression in acute period and remission. Medical Science Monitor 6 (3), 539-547.
47. Raison, C.L., Capuron, L., Miller, A.H., 2006. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends in Immunology 27, 24-31.
48. Repetto, M., Reides, C., Gomez Carretero, M.L., Costa, M., Griemberg, G., Llesuy, S., 1996. Oxidative stress in blood of HIV infected patients. Clinica Chimica Acta 255, 107-117.
49. Rytilä, P., Rehn, T., Ilumets, H., Rouhos, A., Sovijärvi, A., Myllärniemi, M., Kinnula, V.I., 2006. Increased oxidative stress in asymptomatic current chronic smokers and GOLD stage 0 COPD. Respiratory Research 7, 69.
50. Sansone, R.A., 2008. Cholesterol quandaries. Psychiatry 5 (3), 22-34.
51. Skilton, M.R., Moulin, P., Terra, J.L., Bonnet, F., 2007. Associations between anxiety, depression, and the metabolic syndrome. Biological Psychiatry 62 (11), 1251-1257.
52. Sublette, M.E., Galfalvy, H.C., Fuchs, D., Lapidus, M., Grunebaum, M.F., Oquendo, M. A., John Mann, J., Postolache, T.T., 2011. Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder. Brain, Behavior, and Immunity 25, 1272-1278.
53. Talarowska, M., GaJecki, P., Maes, M., Orzechowska, A., Chamielec, M., Bartosz, G., Kowalczyk, E., 2012. Nitric oxide plasma concentration associated with cognitive impairment inpatients with recurrent depressive disorder. Neuroscience Letters 510, 127-131.
54. Underwood, M.D., Arango, V., 2011. Evidence for neurodegeneration and neuroplas-ticity as part of the neurobiology of suicide. Biological Psychiatry 70, 306-307.
55. Williams, L.J., Pasco, J.A., Henry, M.J., Jacka, F.N., Dodd, S., Nicholson, G.C., Kotowicz, M.A., Berk, M., 2009. Lifetime psychiatric disorders and body composition: a population-based study. Journal of Affective Disorders 118 (1-3) 173-9.
56. Witko-Sarsat, V., Friedlander, M., Capeillere-Blandin, C, Nguyen-Khoa, C., Nguyen, T., Zingraff, A.T., Jungers, J., Deschamps-Latscha B., P., 1996. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney International 4, 1304-1313.
57. World Health Organization (WHO), 2002. The alcohol, smoking and substance involvement screening test (ASSIST): development, reliability and feasibility. Addiction 97 (9), 1183-1194.